We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP38442
Poster Title: Metabolomics Core Facility provides ready to use data exploration with MetaboScape
Submitted on 09 Mar 2022
Author(s): Jörg Büscher 1 , Sofie Weinkouff 2 , Ansgar Korf 2 , Aiko Barsch 2 , Nikolas Kessler 2
Affiliations: 1 Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany 2 Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany
Poster Views: 446
Submitted on 09 Mar 2022
Author(s): Jörg Büscher 1 , Sofie Weinkouff 2 , Ansgar Korf 2 , Aiko Barsch 2 , Nikolas Kessler 2
Affiliations: 1 Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany 2 Bruker Daltonics GmbH & Co. KG, 28359 Bremen, Germany
Poster Views: 446
Abstract: Core facilities in academic institutions provide services and instrument access to research labs that by themselves lack the expertise and/or resources to perform metabolomics experiments. This involves working with tens to hundreds of users with greatly varying levels of knowledge in metabolomics and analytical technology. Whilst designing metabolomics experiments and acquiring data is typically performed by specialized and trained staff, successful data processing, in particular for untargeted metabolomics, requires knowledge of the experimental system and the experimental design. Ideally, experts from the core facility and users from the research labs review the data together.Summary: Whilst designing metabolomics experiments and acquiring data is typically performed by specialized and trained staff, successful data processing, in particular for untargeted metabolomics, requires knowledge of the experimental system and the experimental design.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Science lab Report on H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
Abstract 23: Precision medicine approaches to Fanconi anemia oral cancer personalized prevention and treatment
Daniel K. Swenson; Beverly R. Wuertz; Mustafa M. Ali; Gretchen M. Unger; Frank G. Ondrey
Genomic analysis points to changes in markers of stemness in oral cancer progression
Gretchen M. Unger, Beverly R. Wuertz, Patrick M. Gaffney, Frank G. Ondrey.
Method of Host Cell Protein Analysis
Creative Proteomics